THE U.S. GOVERNMENT GAVE AT LEAST $30 million in federal grants for research led by a scientist who is now working for Beijing. Song-Chun Zhu is at the forefront of China's race to develop the most advanced artificial intelligence research that he compared to the development of the atomic bomb in terms of military importance.
Pentagon funding for Zhu, the former director of a pioneering AI center at the University of California Los Angeles (UCLA), continued even as he set up a parallel institute near Wuhan, took a position at a Beijing university whose primary goal is to support Chinese military research and joined a Chinese Communist Party "talent plan" whose members are tasked with transferring knowledge and technology to China.
Newsweek's reporting underlines how the United States, with its open academic environment, has not only been a source for China of advanced technology with military applications but has also actively collaborated with and funded scientists from its rival. Only as tensions with China have grown over everything from global flashpoints to trade to technology, has the research started coming under growing scrutiny.
Responding to Newsweek's questions over funding for Zhu, the Department of Defense says there were also advantages to international collaboration: not least being able to recruit top minds from around the globe, including China, to the United States. The statement adds, "For all of our R&D programs, the Department has policies, including comprehensive disclosure requirements, that address research security challenges and conflicts of interest."
The National Science Foundation, a federal agency that was among those that awarded millions of dollars in grants to Zhu, began to use new analytic tools to fully determine potential conflicts of interest in 2022.
هذه القصة مأخوذة من طبعة November 17, 2023 من Newsweek US.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة November 17, 2023 من Newsweek US.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Can Alternative Therapies Treat Cancer?
Doctor and breast cancer survivor Liz O'Riordan addresses misinformation around managing the disease
Falling for Romance
A new book, Nora Ephron at the Movies, celebrates the writer/director best known for her iconic rom-coms and strong female characters
Cracking the Norse Code
Walrus DNA has shown that Vikings were likely the first to have encountered Indigenous North Americans
Monumental Shift
The discovery of 165-million-year-old crystals Easter Island has upended the longheld notion of how the Earth's \"conveyor belt\" moves
'OUR FOREIGN POLICY AND DOMESTIC REFORMS ARE TWO SIDES OF THE SAME COIN'
It is a well-known fact across the globe that the North Korean regime is irrational and unpredictable, but we have been consistent in strengthening our defense posture against the threat from North Korea since the Korean War, and I believe that their conventional capability is much inferior to that of the Korean military.
'They Read My Eulogy As I Lay in an Open Grave'
Like Paris Hilton, Natasia Pelowski claims she was subjected to abuse at a teenage therapy program
Russian Economy Faces 'Burnout
Vladimir Putin admits difficulties” as the country’s key interest rate reaches a historic high
China's 'Silent Chemical War'
The U.S. must investigate Beijing's role in the manufacturing of fentanyl that is killing Americans, says one mom whose daughter died after accidentally taking the illicit substance
HARSH HEADWINDS
President Yoon Suk Yeol's BATTLE to reform a South Korea beset with structural problems under the specter of an increasingly aggressive neighbor to THE NORTH
Bridget Everett
BRIDGET EVERETT NEVER THOUGHT SHE'D BE THE LEAD OF A TV SHOW. \"I come from the downtown world in New York, a cabaret singer, and these things just don't happen, you don't find yourself with three seasons of HBO.
